SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2004 / Cilt: 10 - Sayı: 3

Primary carcinoma of fallopian tube: Presentation of two cases

Süha SÖNMEZ
kadir SAVAN
LEVENT YAŞAR
Yakup ŞENSOY
Pages
228–229
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because rare occurence of PFTC, clinical manifestations and the treatment results of cases we presented may be a part of other meta-analysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We diagnosed two cases with primary carcinoma of fallopian tube (PFTC), in a short time period, between February and April 2001 and presented them due to rare occurence of PFTC.
📊
Key Findings & Data:Both cases were postmenopausal women with high serum CA 125 levels and vaginal bleeding.
💡
Conclusion & Impact:Because rare occurence of PFTC, clinical manifestations and the treatment results of cases we presented may be a part of other meta-analysis.
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Fallop tüpü neoplazmları · Fallop tüpleri · Karsinom

Abstract

We diagnosed two cases with primary carcinoma of fallopian tube (PFTC), in a short time period, between February and April 2001 and presented them due to rare occurence of PFTC. Both cases were postmenopausal women with high serum CA 125 levels and vaginal bleeding. PFTC was diagnosed after hysterectomy and bilateral salpingooopherectomy in the case with early disease who was being followed-up for a simple ovarian cyst for 1.5 years. We performed debulking surgery in the case with bulky tumor. Gradually elevation of serum CA 125 level preoperatively, in the case with early disease during the follow-up for ovarian cyst and postoperatif remission without chemotherapy may be a remarkable event. Because rare occurence of PFTC, clinical manifestations and the treatment results of cases we presented may be a part of other meta-analysis.

🔖

Cite This Article

SÖNMEZ, S., SAVAN, K., YAŞAR, L., ŞENSOY, Y. (2004). Primary carcinoma of fallopian tube: Presentation of two cases. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 10 - Sayı: 3, 228–229. https://ajindex.com/articles/227587

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hu CY, Taymor ML, Hertig AT. Primary carcinoma of the fallopian tube.Am J Obstet Gynecol 1950; 59:58-67. 2.Me Murray EH, Jacobs AJ, Perez CA. Carcinoma of the fallopian tube. Management and sites of failure. Cancer 1986; 58:2070-5. 3.Aydınlı K, Bozkurt S, Erkün E, Atasu T. Kadın Genital Kanserlerinin İnsidansı. Jinekoloji ve Obstetrik Dergisi 1987; 1:33. 4.Erez S, Kaplan AL, Wall JA. Clinical Staging of Carcinoma of the uterine tube. Obstet Gynecol 1967; 30:547. 5.Schneider C, Wight E, Perucchini D, Haller U, Fink D. Primary carcinoma of the fallopian tube. A report of 19 cases with the literature review. Eur J Gynaecol Oncol 2000; 21:578-82. 6.Baekelandt M, Nesbakken JA, Kristensen GB, Trope CG, Abeler VM. Carcinoma of the fallopian tube. Cancer 2000; 89:2076-84. 7.Gemignani ML, Hensley ML, Cohen R, Venkatraman E,Saigo PE, Barakat RR. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol 2001; 80:16-20. 8.Alvarado CI, Young RH, Vamvakas EC, Scully RE.Carcinoma of the fallopian tube: a clinicopathological staging of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 1999; 72:367-79. 9.Tolunay G, Demir B, Boran N, Kayıkçıoğlu F, Köse F. Retrospective Analysis of 16 cases of Primary Tuba Adenocarcinorna. GORM 2001; 7:155-8. lO.Hefler LA, Rosen AC, Graf AH, et al. The clinical value of serum concentrations of CA125 in patients with PFTC. Cancer 2000; 89:1555-60. 11.Cheung AN, Ngan HY, Cheng D,et al. Clinicopathologic study of 16 cases of primary tubal malignancy. Int J Gynecol Cancer 1994; 4:111-8. 12.Kurjak A, Kupesic S, Jacobs I. Preoperative diagnosis of the PFTC by three-dimensional static and power Doppler sonography. Ultrasound Obstet Gynecol 2000; 15:246-51. 13.Gadducci A, Landoni F, Sartori E, et al. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol 2002; 81:150-9. 14.Wagenaar HC, Pecorelli S, Vergote I, et al. Phase II study of combination of cyclophosphamide, adriamycine, and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study.Eur J Gynaecol Oncol. 2001; 22:187-93.